Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Forms Pediatric Ethics Subcommittee

This article was originally published in The Pink Sheet Daily

Executive Summary

The advisory panel will address pediatric ethical issues and IRB referrals related to clinical investigations involving children. The subcommittee's preliminary recommendations will be presented to the new Pediatric Advisory Committee.

You may also be interested in...



Dextroamphetamine Study Including Healthy Children Will Be First Test For Pediatric Ethics Subcommittee

NIH study proposes single-dose administration to both children with attention deficit/hyperactivity disorder and healthy volunteers. Institutional Review Board requested special review from HHS after two divided votes.

Dextroamphetamine Study Including Healthy Children Will Be First Test For Pediatric Ethics Subcommittee

NIH study proposes single-dose administration to both children with attention deficit/hyperactivity disorder and healthy volunteers. Institutional Review Board requested special review from HHS after two divided votes.

SSRIs And Suicide To Be Discussed By Pediatric Advisory Cmte. In September

Joint session with Psychopharmacologic Advisory Committee will be new cross-center committee's first meeting.

Topics

UsernamePublicRestriction

Register

OM013658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel